__timestamp | Bio-Techne Corporation | Xenon Pharmaceuticals Inc. |
---|---|---|
Wednesday, January 1, 2014 | 106352000 | 5903000 |
Thursday, January 1, 2015 | 144969000 | 2762000 |
Friday, January 1, 2016 | 162364000 | 1114000 |
Sunday, January 1, 2017 | 188462000 | 25573000 |
Monday, January 1, 2018 | 210850000 | 6000000 |
Tuesday, January 1, 2019 | 240515000 | 38845000 |
Wednesday, January 1, 2020 | 255497000 | 50523000 |
Friday, January 1, 2021 | 298182000 | 75463000 |
Saturday, January 1, 2022 | 349103000 | 105767000 |
Sunday, January 1, 2023 | 366887000 | 167512000 |
Monday, January 1, 2024 | 389335000 |
Unveiling the hidden dimensions of data
In the ever-evolving biotech industry, understanding cost dynamics is crucial for investors and stakeholders. Bio-Techne Corporation and Xenon Pharmaceuticals Inc. offer a fascinating case study. From 2014 to 2023, Bio-Techne's cost of revenue surged by approximately 266%, reflecting its aggressive growth strategy. In contrast, Xenon Pharmaceuticals experienced a staggering 2,736% increase, albeit from a much smaller base, highlighting its rapid expansion phase.
Bio-Techne's cost of revenue consistently grew, peaking in 2023, while Xenon Pharmaceuticals saw a dramatic rise, especially from 2020 onwards. This trend underscores the varying operational scales and market strategies of these companies. Notably, data for 2024 is incomplete, suggesting potential shifts in the coming year. Investors should watch these trends closely, as they offer insights into the companies' financial health and strategic directions.
Cost of Revenue Comparison: AbbVie Inc. vs Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down Merck & Co., Inc. and Bio-Techne Corporation's Expenses
Cost Insights: Breaking Down Pfizer Inc. and Xenon Pharmaceuticals Inc.'s Expenses
Cost of Revenue Comparison: Bio-Techne Corporation vs Grifols, S.A.
Comparing Cost of Revenue Efficiency: Bio-Techne Corporation vs Bausch Health Companies Inc.
Comparing Cost of Revenue Efficiency: Bio-Techne Corporation vs Mesoblast Limited
Cost of Revenue: Key Insights for Bio-Techne Corporation and Taro Pharmaceutical Industries Ltd.
Cost of Revenue Comparison: Grifols, S.A. vs Xenon Pharmaceuticals Inc.
Analyzing Cost of Revenue: Xenon Pharmaceuticals Inc. and HUTCHMED (China) Limited
Cost of Revenue: Key Insights for Xenon Pharmaceuticals Inc. and Mesoblast Limited
Analyzing Cost of Revenue: Xenon Pharmaceuticals Inc. and Agios Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Xenon Pharmaceuticals Inc. and Geron Corporation